1. Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia. Issue 7 (10th March 2021) Authors: O'Brien, Maureen M.; Alonzo, Todd A.; Cooper, Todd M.; Levine, John E.; Brown, Patrick A.; Slone, Tamra; August, Keith J.; Benettaib, Bouchra; Biserna, Noha; Poon, Jennifer; Patturajan, Meera; Chen, Nianhang; Simcock, Mathew; Zimmerman, Linda; Kolb, E. Anders Journal: Pediatric blood & cancer Issue: Volume 68:Issue 7(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗